Orphan drugs are medications designed to treat rare diseases. These conditions often affect a small number of patients. Due to limited market potential, pharmaceutical companies may overlook them. Governments provide incentives to encourage research and development. This support helps improve access to essential treatments. Orphan drugs play a crucial role in addressing unmet medical needs. They can significantly enhance the quality of life for affected individuals.
Orphan drugs have become a focal point in India's healthcare discussions, particularly following the National Policy for Rare Diseases (NPRD) established in 2021. This policy aimed to create...
